Trastuzumab (HLX02) plus Pertuzumab as Dualtarget Neoadjuvant Therapy for HER2-positive Breast Cancer: A Real-World Study Yin Liu,Wen-Jia Zuo,Ruo-Xi Wang,Zhong-Hua Wang,Zhi-Ming ShaoCANCER RESEARCH(2023)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要